Moreover, the nonspecific PDE inhibitor theophylline has anti-inflammatory properties and is used as additional therapy for patients with asthma or chronic obstructive pulmonary disease (COPD) [4]. Here, ALDH7A1 is linked to chronic obstructive pulmonary disease.